Cathie Wood and Ark Invest sold roughly $7,379,804 worth of Palantir stock — and spent $9,145,824 on three biotech stocks.

EST Cathie Wood’s ARK Investment buys 187K shares of Crispr Therapeutics (CRSP) todayMaximize Your Portfolio with Data Driven ...

EST Cathie Wood’s ARK Investment buys 77.6K shares of 10x Genomics (TXG) todayMaximize Your Portfolio with Data Driven Insights:Leverage ...

Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.

Cathie Wood, chief of Ark Investment Management, believes in tech stocks that will have a “disruptive” impact in the future. She often trims her stakes to lock up profits. Sometimes, her strategy ...

Cathie Wood, chief of Ark Investment Management, believes in tech stocks that will have a disruptive impact. She isn’t afraid ...

Ark Invest CEO Cathie Wood on Tuesday shared her insights on crypto regulations under President Trump and Bitcoin's (CRYPTO: BTC) evolving role in financial markets.

ServiceNow reported a mixed fourth quarter, forecasting subscription revenue that was just shy of Wall Street estimates, ...

We recently published a list of 10 AI Stocks Analysts Are Focusing On These Days. In this article, we are going to take a look at where Tempus AI, Inc (NASDAQ:TEM) stands against other AI stocks ...

Despite the passive investing boom, there’s still growing demand for actively managed exchange-traded fund (ETF) solutions.

Cathie Wood, the woman behind the scenes over at Ark Invest, is still taking a proactive approach to play what she believes ...

We recently compiled a list of the 10 Tech Stocks to Sell Now According to Cathie Wood. In this article, we are going to take ...